https://yap-tead-inhibitor1.co....m/increased-diagnosi
The present study involved 22 newborns diagnosed with ductal-dependent congenital heart disease (CCHD) and receiving PGE1 infusions for a duration exceeding one week. To assess pyloric thickness and length, pre-infusion and one week post-infusion ultrasonography of the subject was performed following the PGE1 infusion. ClinicalTrials.gov identifier was assigned
Like
Comment
Share
